Pharmagreen Biotech Inc
Pharmagreen Biotech Inc. operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. The company's primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. It also provides consulting services for plant genetic selection, tissue … Read more
Pharmagreen Biotech Inc (PHBI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.001x
Based on the latest financial reports, Pharmagreen Biotech Inc (PHBI) has a cash flow conversion efficiency ratio of 0.001x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.82K) by net assets ($-2.57 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Pharmagreen Biotech Inc - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Pharmagreen Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Pharmagreen Biotech Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pharmagreen Biotech Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CHESAPEAKE UTIL
BE:CH5
|
0.054x |
|
Fimperkasa Utama Tbk PT
JK:FIMP
|
-0.056x |
|
SBC Medical Group Holdings Incorporated
NASDAQ:SBCWW
|
-0.084x |
|
Gaon Group Ltd
TA:GAGR
|
0.026x |
|
STATE STREET - Dusseldorf Stock Exchang
DU:ZYA
|
0.105x |
|
OSHKOSH
BE:OK3
|
0.079x |
|
SRIVARU Holding Limited
PINK:SVUHF
|
N/A |
|
HYUNGJI INNOVATION & CREATIVE Co.Ltd
KQ:011080
|
-0.071x |
Annual Cash Flow Conversion Efficiency for Pharmagreen Biotech Inc (2008–2024)
The table below shows the annual cash flow conversion efficiency of Pharmagreen Biotech Inc from 2008 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-09-30 | $-3.13 Million | $-28.09K | 0.009x | -73.53% |
| 2023-09-30 | $-2.18 Million | $-73.84K | 0.034x | -85.54% |
| 2022-09-30 | $-1.82 Million | $-426.57K | 0.234x | +92.23% |
| 2021-09-30 | $-1.69 Million | $-206.08K | 0.122x | -41.21% |
| 2020-09-30 | $-2.93 Million | $-607.63K | 0.207x | -45.63% |
| 2019-09-30 | $-834.50K | $-317.83K | 0.381x | -32.73% |
| 2018-09-30 | $-1.39 Million | $-785.53K | 0.566x | +134.44% |
| 2017-09-30 | $-87.29K | $-21.08K | 0.242x | +528.75% |
| 2008-09-30 | $29.63K | $-1.67K | -0.056x | -- |